Skip to main content

Ultimovacs ASA: Cancellation of subsequent repair offering

Written by Customer Service on . Posted in Public Companies.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Oslo, 13 February, 2025: Reference is made to the stock exchange announcement published by Ultimovacs ASA (“Ultimovacs” or the “Company”) on 17 December 2024 regarding the agreement to combine its business with Zelluna Immunotherapy AS, the fully committed private placement (the “Private Placement”), and the intention to carry out a subsequent repair offering (the “Subsequent Offering”), depending, inter alia, on the development of the price of the shares in the Company after completion of the Private Placement. 

The board of directors of the Company has resolved not to proceed with the Subsequent Offering. 

The background for the cancellation is that the Company’s shares have traded at or below the subscription price in the Private Placement for an extended period of time and at sufficient volumes. Shareholders wishing to reduce the dilutive effect of the Private Placement have thus had the opportunity to purchase shares in the market at prices at or below the price which would have been the subscription price in the Subsequent Offering.

For further information, please see www.ultimovacs.com or contact:

Hans Vassgård Eid, CFO and Interim CEO, Ultimovacs ASA 
Email: hans.eid@ultimovacs.com 
Phone: +47 482 48632 
 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.